MRK News Today | Why did Merck & Co., Inc. stock go down today? $MRK

Merck says both remigromig doses met BRUNELLO's Week 52 vision endpoint, while higher eye complication rates remain undisclosed.

Merck & Co. stock traded at USD 148.11 on September 23, 2026, 5.61 percent below its 52-week high. Q

Envestnet Asset Management Inc. aumentó su participación en acciones de Merck & Co., Inc. (NYSE:MRK - Free Report) en un 3,7% en el segundo trimestre, según su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). El fondo poseía 3.996.890 acciones de la empresa.

Envestnet Portfolio Solutions Inc. aumentó su participación en acciones de Merck & Co., Inc. (NYSE:MRK - Free Report) en un 28,3% en el segundo trimestre, según la compañía en su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). La empresa poseía 105.500 acciones de la empresa.

At the close on September 23, 2026, Merck stock was at USD 146.94 on the NYSE, down 2.63 percent. Th

Merck & Co. stock reached USD 151.00 on September 23, 2026, with a USD 372.32 billion market cap. Q2

QRG Capital Management Inc. trimmed its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 14.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 428,993 shares of the company

In the latest trading session, Merck (MRK) closed at $148.08, marking a -1.88% move from the previous day.

At the close on September 22, 2026, Merck stock finished higher after a Japan approval for KEYTRUDA

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Merck & Co. stock closed at USD 143.76 on September 15, 2026, down 0.17 percent. Revenue reached USD